Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Nov 17, 2020

32106_dirs_2020-11-16_4474bcfd-0721-45c1-be56-6dd7329c9d4d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-12

Reporting Person: Schick Joseph C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-12 Common Stock M 5000 $1.90 Acquired 16875 Direct
2020-11-12 Common Stock S 6250 $33.12 Disposed 10625 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-12 Stock Option (Right to Buy) $1.90 M 5000 Disposed 2026-03-15 Common Stock (5000) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: The options vested 100% on the first anniversary of the grant date.